TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11896839

Group type: EXPERIMENTAL
Intervention: Removable partial denture with plaque control and professional prophylaxis
Number of subjects: 30

Group type: COMPARATOR
Intervention: Removable partial denture without plaque control and professional prophylaxis
Number of subjects: 30
Study: 9707453

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy (LC)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Open cholecystectomy (OC)
Number of subjects: 26
Study: 8005278

Group type: EXPERIMENTAL
Intervention: i.v. administration of 50 g of human albumin diluted in 500 mL of sodium chloride 0.9%
Number of subjects: 31

Group type: COMPARATOR
Intervention: sodium chloride 0.9% solution
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 31
Study: 2686741

Group type: EXPERIMENTAL
Intervention: Cefadroxil 1 g twice daily
Number of subjects: 111

Group type: COMPARATOR
Intervention: Amoxycillin 500 mg three times a day
Number of subjects: 111
Study: 782262

Group type: EXPERIMENTAL
Intervention: Amantadine
Number of subjects: 39

Group type: COMPARATOR
Intervention: Trihexyphenidyl
Number of subjects: 39
Study: 12454840

Group type: EXPERIMENTAL
Intervention: Entecavir 0.1 mg/day
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Entecavir 0.5 mg/day
Number of subjects: 169

Group type: COMPARATOR
Intervention: Lamivudine 100 mg/day
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Entecavir 0.1 mg/day and 0.5 mg/day
Number of subjects: 169
Study: 31960071

Group type: EXPERIMENTAL
Intervention: Moderate continuous training combined with resistance training (RT)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: High-intensity interval training with RT
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group (non-exercise)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: CRF responders (exercise group with improved CRF)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: CRF non-responders (exercise group without improved CRF)
Number of subjects: 63
Study: 29891215

Group type: EXPERIMENTAL
Intervention: Active ECT (N=15)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Sham (N=12)
Number of subjects: 27
Study: 27659102

Group type: EXPERIMENTAL
Intervention: Self-referral to inpatient treatment (contract for self-referral, maximum 5 days, quarantine time of 14 days between stays)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 53
Study: 24797321

Group type: EXPERIMENTAL
Intervention: ADH1B*2/*2 group with 0.25 g/kg EtOH
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: ADH1B*2/*2 group with 0.5 g/kg EtOH
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: ADH1B*2/*2 group at all dosages of EtOH
Number of subjects: 24

Group type: COMPARATOR
Intervention: ADH1B*1/*2 group at 0.5 g/kg EtOH
Number of subjects: 24
Study: 22928903

Group type: EXPERIMENTAL
Intervention: Early dental treatment for severe dental caries
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control (regular dental treatment)
Number of subjects: 86
Study: 20361072

Group type: EXPERIMENTAL
Intervention: SCM‐III symbiotic mixture, 10 ml three times a day
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: SCM‐III symbiotic mixture
Number of subjects: 46
Study: 18519826

Group type: EXPERIMENTAL
Intervention: Nicotine Replacement Therapy (NRT)
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: Bupropion hydrochloride
Number of subjects: 550

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 550
Study: 15643674

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral intervention (10-contact, 18-week duration)
Number of subjects: 237

Group type: COMPARATOR
Intervention: Conventional care (control group)
Number of subjects: 237
Study: 12042548

Group type: EXPERIMENTAL
Intervention: ELA-Max (4% liposomal lidocaine)
Number of subjects: 120

Group type: COMPARATOR
Intervention: EMLA (eutectic mixture of local anesthetics)
Number of subjects: 120
Study: 10210074

Group type: EXPERIMENTAL
Intervention: Patellar tendon (PT)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Semitendinosus (ST)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Semitendinosus and gracilis (ST/G)
Number of subjects: 106
Study: 7610222

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatment
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Social support therapy
Number of subjects: 72

Group type: COMPARATOR
Intervention: No-treatment control condition
Number of subjects: 72
Study: 2379533

Group type: EXPERIMENTAL
Intervention: Furegrelate 800 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Furegrelate 1600 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Furegrelate (all doses)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Furegrelate (higher doses)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Furegrelate
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 319355

Group type: EXPERIMENTAL
Intervention: Amikacin
Number of subjects: 174

Group type: COMPARATOR
Intervention: Gentamicin
Number of subjects: 174
Study: 31321514

Group type: EXPERIMENTAL
Intervention: Causal DNA methylations and gene expressions for MS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Causal genes enriched in KEGG pathways and GO terms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MS-associated SNPs in DDR1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Plasma MICB and Granzyme A levels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: m6A-SNPs rs923829 and METTL21B expression level
Number of subjects: 0
Study: 28647451

Group type: EXPERIMENTAL
Intervention: Mindfulness, cognitive based therapy
Number of subjects: 179
Study: 26195978

Group type: EXPERIMENTAL
Intervention: Cognitive Interventions (CI)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Physical Activities (PA)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Group Reminiscence Approach (GRA)
Number of subjects: 127
Study: 23513242

Group type: EXPERIMENTAL
Intervention: Nonfibrotic ILA
Number of subjects: 884

Group type: EXPERIMENTAL
Intervention: Fibrotic ILA
Number of subjects: 884

Group type: COMPARATOR
Intervention: Overall prevalence of ILA
Number of subjects: 884

Group type: COMPARATOR
Intervention: Equivocal for ILA
Number of subjects: 884

Group type: COMPARATOR
Intervention: Fibrotic ILA pattern
Number of subjects: 884

Group type: COMPARATOR
Intervention: Nonfibrotic ILA pattern
Number of subjects: 884

Group type: COMPARATOR
Intervention: Mixed fibrotic and nonfibrotic ILA pattern
Number of subjects: 884
Study: 21528593

Group type: EXPERIMENTAL
Intervention: Acupuncture at acupoints selected according to syndrome differentiation (Fengchi (GB 20), Quchi (LI 11), Zusanli (ST 36), Sanyinjiao (SP 6) plus supplementary points according to syndrome differentiation)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Control group received acupuncture at main points only (Fengchi (GB 20), Quchi (LI 11), Zusanli (ST 36), Sanyinjiao (SP 6))
Number of subjects: 135
Study: 19447837

Group type: EXPERIMENTAL
Intervention: 0.006 microg/kg/min IV BNP for 72 h
Number of subjects: 24

Group type: COMPARATOR
Intervention: 0.003 microg/kg/min IV BNP for 72 h
Number of subjects: 24
Study: 16456433

Group type: EXPERIMENTAL
Intervention: Brief Intervention (BI), average duration 30 minutes, performed by social worker or trauma surgeon
Number of subjects: 126

Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Brief Intervention (BI)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Prior number of DUIs
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Alcohol screening score
Number of subjects: 126
Study: 14722028

Group type: EXPERIMENTAL
Intervention: Hyperglycemic clamp at 15 mM (trial B)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Hyperinsulinemic euglycemic clamp (trial C)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Normoglycemia (trial A, control)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: All trials (A, B, C)
Number of subjects: 10
Study: 12164031

Group type: EXPERIMENTAL
Intervention: Weekly oral iron supplementation (100 mg elemental iron)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Thrice weekly oral iron supplementation (100 mg elemental iron)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Daily oral iron supplementation (100 mg elemental iron)
Number of subjects: 92
Study: 9165507

Group type: EXPERIMENTAL
Intervention: Toremifene (Fareston)
Number of subjects: 830

Group type: COMPARATOR
Intervention: Tamoxifen (Nolvadex)
Number of subjects: 830
Study: 8199073

Group type: EXPERIMENTAL
Intervention: Independent counselling by an experienced psychotherapist
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (no independent counselling)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Termination of pregnancy
Number of subjects: 57
Study: 3555430

Group type: COMPARATOR
Intervention: Symmetric medial rectus recessions with posterior fixation sutures
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Symmetric medial rectus recessions without posterior fixation sutures, augmented according to formula
Number of subjects: 0
Study: 29738462

Group type: COMPARATOR
Intervention: acidified milk protein drink
Number of subjects: 29

Group type: COMPARATOR
Intervention: placebo control
Number of subjects: 29
Study: 27354202

Group type: EXPERIMENTAL
Intervention: Amitriptyline (tricyclic antidepressant)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo pill with conditioned stimulus (novel-tasting drink)
Number of subjects: 39
Study: 24742146

Group type: EXPERIMENTAL
Intervention: Tai Chi Chuan (TCC) training, 5 days per week for 1 hour per day for 12 weeks
Number of subjects: 206

Group type: COMPARATOR
Intervention: No specific exercise (Control group)
Number of subjects: 206
Study: 24370801

Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 71

Group type: COMPARATOR
Intervention: Low-dose fentanyl
Number of subjects: 71
Study: 20216117

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) dosing regimens (fixed and concentration-controlled)
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 219
Study: 18480832

Group type: EXPERIMENTAL
Intervention: 7-day automatic ambulatory BP monitoring (ABPM) in prediabetics
Number of subjects: 0

Group type: COMPARATOR
Intervention: 7-day automatic ambulatory BP monitoring (ABPM) in normoglycemics
Number of subjects: 0
Study: 15876471

Group type: EXPERIMENTAL
Intervention: Genotypic screening strategy (saliva sample taken at home)
Number of subjects: 3000

Group type: COMPARATOR
Intervention: Phenotypic screening strategy (transferrin saturation on blood sample taken at GP surgery)
Number of subjects: 3000
Study: 14696994

Group type: EXPERIMENTAL
Intervention: Voice amplification using the ChatterVox portable amplifier (VA; n = 25)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Resonance therapy (RT; n = 19)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Respiratory muscle training (RMT; n = 20)
Number of subjects: 64
Study: 10559510

Group type: EXPERIMENTAL
Intervention: COPD patients
Number of subjects: 90

Group type: COMPARATOR
Intervention: Normal subjects (controls)
Number of subjects: 90
Study: 8723140

Group type: EXPERIMENTAL
Intervention: Botulinum toxin (BTX) type A, 50 U
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 1912429

Group type: EXPERIMENTAL
Intervention: misoprostol 200 micrograms q.i.d. for 4-8 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 50
Study: 7037301

Group type: EXPERIMENTAL
Intervention: IMV4
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: PEEP10
Number of subjects: 9

Group type: COMPARATOR
Intervention: IPPV12
Number of subjects: 9

Group type: COMPARATOR
Intervention: PEEP0
Number of subjects: 9
Study: 30246555

Group type: EXPERIMENTAL
Intervention: Blood flow restriction limb
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control limb
Number of subjects: 20
Study: 29801398

Group type: EXPERIMENTAL
Intervention: R-CHOP
Number of subjects: 100

Group type: COMPARATOR
Intervention: CHOP
Number of subjects: 100
Study: 26231884

Group type: EXPERIMENTAL
Intervention: Exercise training (4-7 days/week)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control group (no exercise training)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 87
Study: 25099167

Group type: EXPERIMENTAL
Intervention: CCR (Canadian C-Spine Rule)
Number of subjects: 378

Group type: COMPARATOR
Intervention: CCHR (Canadian CT Head Rule)
Number of subjects: 378
Study: 22291042

Group type: EXPERIMENTAL
Intervention: VRT and tDCS
Number of subjects: 8

Group type: COMPARATOR
Intervention: VRT and sham
Number of subjects: 8
Study: 19465188

Group type: EXPERIMENTAL
Intervention: High-sugar/low-fiber meal
Number of subjects: 10

Group type: COMPARATOR
Intervention: Low-sugar/high-fiber meal
Number of subjects: 10
Study: 17848323

Group type: EXPERIMENTAL
Intervention: Laparoscopic‐assisted vaginal hysterectomy (LAVH)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Minilaparotomy hysterectomy
Number of subjects: 81
Study: 15220165

Group type: EXPERIMENTAL
Intervention: Epidural oxycodone 6 mg day(‐1)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Epidural oxycodone 12 mg day(‐1)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Epidural morphine 6 mg day(‐1)
Number of subjects: 75
Study: 11399136

Group type: EXPERIMENTAL
Intervention: Cup feeding of breast milk
Number of subjects: 14

Group type: COMPARATOR
Intervention: Bottle feeding of breast milk
Number of subjects: 14
Study: 9921699

Group type: EXPERIMENTAL
Intervention: Mirtazapine and subsequent lithium addition
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Imipramine and subsequent lithium addition
Number of subjects: 100

Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Lithium addition to either imipramine or mirtazapine
Number of subjects: 100
Study: 7906759

Group type: EXPERIMENTAL
Intervention: Bismuth subcitrate, tetracycline, and metronidazole (1-week course)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Omeprazole (4 weeks) with bismuth subcitrate, tetracycline, and metronidazole (1-week course)
Number of subjects: 132
Study: 3290622

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Conventional insulin treatment (UCT)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: CSII
Number of subjects: 16

Group type: COMPARATOR
Intervention: UCT
Number of subjects: 16
Study: 1375801

Group type: EXPERIMENTAL
Intervention: Risperidone (12 mg daily)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Haloperidol (10 mg daily)
Number of subjects: 44
Study: 196232

Group type: EXPERIMENTAL
Intervention: Chronic cerebellar stimulation
Number of subjects: 8

Group type: COMPARATOR
Intervention: Intermittent cerebral cortical stimulation
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Cerebellar stimulation
Number of subjects: 8

Group type: COMPARATOR
Intervention: Cerebral surface stimulation
Number of subjects: 8
Study: 31707288

Group type: EXPERIMENTAL
Intervention: BresoDx
Number of subjects: 233

Group type: COMPARATOR
Intervention: PSG
Number of subjects: 233
Study: 31590437

Group type: EXPERIMENTAL
Intervention: High-Fiber, Low-GI (HF-LGI) meal
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Low-GI meals (including HF-LGI and LF-LGI)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Low-Fiber, High-GI (LF-HGI) meal
Number of subjects: 11

Group type: COMPARATOR
Intervention: High-Fiber, High-GI (HF-HGI) meal
Number of subjects: 11

Group type: COMPARATOR
Intervention: Low-Fiber, Low-GI (LF-LGI) meal
Number of subjects: 11
Study: 28749198

Group type: EXPERIMENTAL
Intervention: Empathy skills training with simulated patients (SPs)
Number of subjects: 158

Group type: COMPARATOR
Intervention: History course (Control)
Number of subjects: 158
Study: 26059012

Group type: EXPERIMENTAL
Intervention: Cinacalcet
Number of subjects: 2985

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2985
Study: 23852309

Group type: EXPERIMENTAL
Intervention: Bevacizumab plus chemotherapy
Number of subjects: 820

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 820
Study: 21476127

Group type: EXPERIMENTAL
Intervention: Kaolin-based haemostatic bandage
Number of subjects: 200

Group type: COMPARATOR
Intervention: Manual compression
Number of subjects: 200
Study: 19439062

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate-based hydration
Number of subjects: 2633

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 2633
Study: 18693590

Group type: EXPERIMENTAL
Intervention: Dipyridamole pharmacologic stress during myocardial perfusion imaging
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Mild perfusion defects
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Moderate perfusion defects
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Severe perfusion defects
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Fixed defects
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Reversible defects (mild to moderate)
Number of subjects: 30
Study: 15008644

Group type: EXPERIMENTAL
Intervention: Regulatory fit induced by strategic framing of message arguments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Source unrelated to the message
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group with salient source of feeling right before message exposure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Negative message-related thoughts
Number of subjects: 0
Study: 11469475

Group type: EXPERIMENTAL
Intervention: High intensity home‐based progressive strength training program
Number of subjects: 46

Group type: COMPARATOR
Intervention: Nutrition education program (attention control)
Number of subjects: 46
Study: 9628709

Group type: EXPERIMENTAL
Intervention: Education (lifting instructions) and lumbar support
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Education
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Lumbar support
Number of subjects: 282

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Lumbar support (in subgroup with low back pain at baseline)
Number of subjects: 282
Study: 7511740

Group type: EXPERIMENTAL
Intervention: enalapril, lisinopril, or perindopril (ACE inhibitors) for 8-12 weeks
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: lisinopril
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: ACE inhibitor monotherapy
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: ACE inhibitors
Number of subjects: 52
Study: 3257688

Group type: EXPERIMENTAL
Intervention: Sulfamethoxazole and trimethoprim (Bactrim)
Number of subjects: 1

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1
Study: 29287673

Group type: EXPERIMENTAL
Intervention: Bain's system at 5L.min‐1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mapleson A at 5L.min‐1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Circle system at 5L.min‐1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mapleson A at 10L.min‐1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bain's system at 10L.min‐1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Circle system at 10L.min‐1
Number of subjects: 0
Study: 28593720

Group type: EXPERIMENTAL
Intervention: Phytoestrogen-rich natural preparation Karinat
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 26248676

Group type: EXPERIMENTAL
Intervention: Immediate vaccination with rVSV‐ZEBOV (one dose of 2×10^7 plaque‐forming units, administered intramuscularly)
Number of subjects: 7651

Group type: COMPARATOR
Intervention: Delayed vaccination with rVSV‐ZEBOV
Number of subjects: 7651

Group type: EXPERIMENTAL
Intervention: Immediate vaccination with rVSV‐ZEBOV
Number of subjects: 7651
Study: 23065050

Group type: EXPERIMENTAL
Intervention: 27-G Whitacre spinal needle
Number of subjects: 60

Group type: COMPARATOR
Intervention: Quincke spinal needle
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both Whitacre and Quincke needles with 1.2 ml of 0.5% plain bupivacaine
Number of subjects: 60
Study: 22256634

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 120

Group type: COMPARATOR
Intervention: Western medication (Glucosamine Hydrochloride capsules, 2 capsules, 3 times per day)
Number of subjects: 120
Study: 19301989

Group type: EXPERIMENTAL
Intervention: Tapentadol IR (50 or 100 mg, q4-6h, p.o.)
Number of subjects: 878

Group type: COMPARATOR
Intervention: Oxycodone IR (10 or 15 mg, q4-6h, p.o.)
Number of subjects: 878

Group type: EXPERIMENTAL
Intervention: Tapentadol IR
Number of subjects: 878

Group type: COMPARATOR
Intervention: Oxycodone IR
Number of subjects: 878
Study: 16702891

Group type: EXPERIMENTAL
Intervention: Pagoclone (4.8 mg)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Pagoclone (1.2 mg)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Diazepam (30 mg)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 15349004

Group type: EXPERIMENTAL
Intervention: Venlafaxine ER (75 to 225 mg/d)
Number of subjects: 272

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 272
Study: 11392066

Group type: COMPARATOR
Intervention: 20 mg chlorpheniramine (CPM) before surgery (Control group C, n = 22)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: 40 mg dextromethorphan (DM) and 20 mg CPM before surgery (group B, n = 22)
Number of subjects: 64
Study: 9034938

Group type: EXPERIMENTAL
Intervention: nizatidine 300 mg b.i.d. (N2)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: ranitidine 300 mg b.i.d. (R2)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: nizatidine 300 mg q.h.s. (N1)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: ranitidine 300 mg q.h.s. (R1)
Number of subjects: 6

Group type: COMPARATOR
Intervention: placebo (P)
Number of subjects: 6
Study: 1325613

Group type: COMPARATOR
Intervention: rHuEpo at an initial dose of 50 U/kg thrice weekly, adjusted to maintain Hb 105-120 g/l (group 1)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Usual dose of rHuEpo adjusted to maintain Hb 105-120 g/l (group 2)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: rHuEpo therapy (both groups)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: rHuEpo therapy (group 1)
Number of subjects: 98
Study: 6381612

Group type: EXPERIMENTAL
Intervention: Moxalactam plus ticarcillin (M/T)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Tobramycin plus ticarcillin (T/T)
Number of subjects: 108
Study: 30075543

Group type: EXPERIMENTAL
Intervention: Bronchoscopic sputum suction
Number of subjects: 0

Group type: COMPARATOR
Intervention: General sputum suction
Number of subjects: 0